Considerations for comparative tobacco product assessments based on smoke constituent yields.

Belushkin, M; Jaccard, G; Kondylis, A

Belushkin, M; Jaccard, G; Kondylis, A.

Affiliation

Belushkin M; Philip Morris International R&D, Philip Morris Products S.A., Rue des Usines 90, 2000 Neuchâtel, Switzerland. Electronic address: Maxim.Belushkin@pmi.com.
Jaccard G; Philip Morris International Management SA, Product & Process Quality, Quai Jeanrenaud 56, 2000 Neuchâtel, Switzerland.
Kondylis A; Philip Morrris Products SA, Product Development, Rue des Usines 56, 2000 Neuchâtel, Switzerland.

Regul Toxicol Pharmacol ; 73(1): 105-13, 2015 Oct.

Article in En | MEDLINE | ID: mdl-26140819

Subject(s)

Nicotiana/anatomy & histology; Smoke/analysis; Smoking/adverse effects; Tobacco Products/analysis; Humans

Key words

Cigarette smoke constituent; Quantitative comparisons; Tobacco regulations

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Smoke / Nicotiana / Smoking / Tobacco Products Limits: Humans Language: En Journal: Regul Toxicol Pharmacol Year: 2015 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google